About Curza
Curza is a small-molecule therapeutics company that has developed several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. Curza’s lead program is a new class of broad spectrum antibiotics, focused on ESKAPE pathogens and drug-resistant Gram-negative bacteria. Inspired by a natural product, thisclass targets an unexploited binding site of the bacterial ribosome. With ever increasing reports of resistance to frontline therapies addressing Gram-negative bacteria, there is a critical need for new therapies and new therapies that work in new ways. However, very little can be found in the development pipeline. As a result, Curza’s compounds are addressing a major unmet medical need.
Founded in 2013 by Robert Mooney.
- Founded
- 2013
- Employees
- 11 to 50
- Total funding
- $24.2M
- Headquarters
- Salt Lake City
Leadership
The top of Curza's org chart, with how many people report into each leader.
Chad Testa
CEO
7 reports
Ryan Looper
Vice President of Discovery
5 reports
Nick Skene
Vice President Finance
Jobs at Curza
No open positions right now. Explore more companies on TheJobsMap.